Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients.

NCT02895061 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

502

Enrollment

OTHER

Sponsor class

Conditions

Alfacalcidol, Secondary Hyperparathyroidism, Hemodialysis

Interventions

DRUG: Alfacalcidol

Sponsor

Phramongkutklao College of Medicine and Hospital